Managing the adverse effects of bisphosphonate therapy on the jaw.
Rizzolo
Denise
D
Care Station, Springfield, NJ, USA.
Sedrak
Mona
M
D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000150:complications / Q000188:drug therapy; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007568:Jaw / Q000187:drug effects* / Q000473:pathology; D007571:Jaw Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology; D010020:Osteonecrosis / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D050071:Bone Density Conservation Agents; D004164:Diphosphonates